Skip to main content
OpenTrials
Completed

NCT Number: NCT04910984

Developing a Chatbot to Promote HIV Testing

In this study, the feasibility of a Chatbot in promoting HIV testing in men who have sex with men in Kuala Lumpur, Malaysia will be studied. Participants will receive automated personalized messages containing HIV testing-related information, motivation and skills.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

HIV Infections Blood-Borne Infections Communicable Diseases Genital Diseases Immune System Diseases Immunologic Deficiency Syndromes Infections Lentivirus Infections RNA Virus Infections Retroviridae Infections Sexually Transmitted Diseases Sexually Transmitted Diseases, Viral Urogenital Diseases Virus Diseases

Age range

18 year and older

Sex eligibility

Male

Study type

Observational

Primary location

University of Malaya

Kuala Lumpur, Jalan Pantai Baharu, 59990, Malaysia

About this study

Participants will receive attention-matched educational materials manually sent by the research assistant. In each round of the interactive communication, the Chatbot will provide automated personalized messages containing HIV testing-related information, motivation and skills based on participants' answers and will continuously update over time. An independent assessment of recent testing and reasons why will be sent by link participant using a link to a Qualtrics survey housed on REDCap. The RA will send an additional REDCap survey to intervention participants to assess the feasibility of the Chabot to measure 4 key elements: acceptability, practicality, demand, and adaptation.

Study was changed from Interventional to Observational half way through,. Record was updated accordingly in 2026.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • cis-gender male
  • 18+ years;
  • had condomless sex with men in the past 6 months
  • has a smartphone
  • speaks Bahasa Malay or English.

Exclusion criteria

  • Not able to read Malay or English

Treatment and study plan

Chatbot messages

Behavioral

Automated personalized messages containing HIV testing-related information, motivation and skills

Attention-matched educational materials

Behavioral

Attention-matched educational materials manually sent by our research assistant. These educational materials will be retrieved from CDC and WHO websites and curated into short articles (<200 words) and pictures. All educational materials will be screened by HIV experts from University of Malaya to ensure accuracy before being sent to participants.

Primary outcomes

  1. Change in HIV testing

    Time frame: 30 days, 60 days, 90 days, 120 days, 150 days, and 180 days

    The efficacy of the Chatbot versus TAU with HIV testing as the primary outcome will be measured. The primacy efficacy outcome is the proportion of MSM who get tested within 180 days. This will be measured every 30 days by asking if MSM tested for HIV in the past 30 days.

Secondary outcomes

  1. Recruitment rate

    Time frame: 180 days

    The number of participants contacted divided by the number of participants who signed the consent form

  2. Completion rate

    Time frame: 180 days

    The number of participants who signed the consent form divided by the number of participants who completed the study

  3. Interaction time

    Time frame: 180 days

    The time of the interaction between participants and Chatbot

  4. Interaction frequency

    Time frame: 180 days

    The frequency of the interaction between participants and Chatbot

Sponsors and collaborators

Lead sponsor

Yale University

Other

Collaborators

  • National Institute of Allergy and Infectious Diseases (NIAID)
  • University of Malaya

Registry information

Official study title

Developing an Artificial Intelligence Chatbot to Promote HIV Testing

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Jun 2, 2021
Registry last updated
Sep 21, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.